Inhibrx Biosciences, Inc. (INBX) — Net Asset Quality Index
Inhibrx Biosciences, Inc. (INBX) has a Net Asset Quality Index of 5.5% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $146.48 Million minus total liabilities of $138.49 Million yields net assets of $7.99 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore Inhibrx Biosciences, Inc. balance sheet assets for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Inhibrx Biosciences, Inc. Net Asset Quality Index Over Time (2016–2025)
This chart shows how Inhibrx Biosciences, Inc.'s Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the index stands at 5.5%, representing net assets of $7.99 Million against total assets of $146.48 Million USD. See Inhibrx Biosciences, Inc. (INBX) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Inhibrx Biosciences, Inc. (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for Inhibrx Biosciences, Inc. from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see INBX market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 5.5% | $7.99 Million | $146.48 Million | $138.49 Million | ▼ -68.4 pp |
| 2024 | 73.9% | $133.58 Million | $180.77 Million | $47.18 Million | ▲ +59.8 pp |
| 2023 | 14.1% | $43.50 Million | $307.89 Million | $264.39 Million | ▼ -5.8 pp |
| 2022 | 20.0% | $58.06 Million | $290.88 Million | $232.82 Million | ▼ -14.9 pp |
| 2021 | 34.8% | $52.38 Million | $150.45 Million | $98.07 Million | ▼ -17.7 pp |
| 2020 | 52.5% | $75.47 Million | $143.74 Million | $68.27 Million | ▲ +405.7 pp |
| 2019 | -353.2% | $-93.57 Million | $26.49 Million | $120.06 Million | ▲ +224.1 pp |
| 2018 | -577.4% | $-57.64 Million | $9.98 Million | $67.63 Million | ▼ -447.4 pp |
| 2017 | -130.0% | $-22.42 Million | $17.25 Million | $39.67 Million | ▼ -135.8 pp |
| 2016 | 5.8% | $1.24 Million | $21.27 Million | $20.03 Million | — |